摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-4-amino-5-methylhex-2-enoic acid

中文名称
——
中文别名
——
英文名称
(E)-4-amino-5-methylhex-2-enoic acid
英文别名
——
(E)-4-amino-5-methylhex-2-enoic acid化学式
CAS
——
化学式
C7H13NO2
mdl
——
分子量
143.18
InChiKey
CKELZIJSOFRBOY-ONEGZZNKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.8
  • 重原子数:
    10
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    63.3
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • DEVELOPMENT OF A SYNTHESIS OF SYRINGOLIN A AND B AND DERIVATIVES THEREOF
    申请人:Kaiser Markus
    公开号:US20100022767A1
    公开(公告)日:2010-01-28
    The synthesis of syringolin A and B and derivatives thereof as well as to pharmaceutical compositions containing the syringolin A or B or derivatives thereof and the use of syringolin A and B and derivatives thereof for prophylaxis and treatment of cancer.
    合成Syringolin A和B及其衍生物,以及含有Syringolin A或B或其衍生物的药物组合物的用途,以及Syringolin A和B及其衍生物用于预防和治疗癌症。
  • Derivatives of syringolin A
    申请人:Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
    公开号:EP2210881A1
    公开(公告)日:2010-07-28
    The present invention relates to syringolin A derivatives, the use of the syringolin A derivatives for prophylaxis and treatment of neurodegenerative diseases and proliferative diseases such as cancer, pharmaceutical compositions containing at least one syringolin A derivative as well as to a synthesis for preparing the syringolin A derivatives.
    本发明涉及丝菌素A衍生物,使用丝菌素A衍生物预防和治疗神经退行性疾病和增殖性疾病,如癌症,含有至少一种丝菌素A衍生物的药物组合物,以及制备丝菌素A衍生物的合成方法。
  • PHARMACEUTICAL COMPOSITIONS FOR THE TREAMENT OF CONDITIONS RESPONSIVE TO PROTEASOME INHIBITION
    申请人:Bachmann Andre S.
    公开号:US20100267070A1
    公开(公告)日:2010-10-21
    The invention disclosed herein generally relates to methods and compositions for inhibiting proteasome activity comprising a syrbactin compound have the structure of Formula (I) or (II).
  • PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CONDITIONS RESPONSIVE TO PROTEASOME INHIBITION
    申请人:Pono Corporation
    公开号:US20140187526A1
    公开(公告)日:2014-07-03
    The invention disclosed herein generally relates to methods and compositions for inhibiting proteasome activity comprising a syrbactin compound having the structure of Formula I or II:
  • US8597904B2
    申请人:——
    公开号:US8597904B2
    公开(公告)日:2013-12-03
查看更多